ILF3 and gastric cancer: This study shows that ox-LDL promotes the expression of ILF3 through the PI3K/AKT/mTOR signaling pathway, thus facilitates the proliferation, cell cycle, migration and invasion of gastric cancer cells, providing a potential new biomarker for the early detection and the therapeutic target of gastric cancer patients.